Biodesix, Inc. (BDSX)
USD 1.34
(-3.6%)
USD 1.34
(-3.6%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -22.87 Million | -44.97 Million | -28.22 Million | -21.36 Million | -21.72 Million | -17.67 Million |
| Net Income | -52.14 Million | -65.44 Million | -43.15 Million | -31.35 Million | -30.72 Million | -26.16 Million |
| Depreciation & Amortization | 5.5 Million | 5.84 Million | 3.17 Million | 2.9 Million | 2.79 Million | 1.74 Million |
| Deferred income taxes | 4.03 Million | - | -2.1 Million | 1.59 Million | 2.36 Million | 47 Thousand |
| Stock-based compensation | 5.37 Million | 5.96 Million | 4.94 Million | 3.7 Million | 170 Thousand | 142 Thousand |
| Change in working capital | 11.3 Million | -4.34 Million | 4.59 Million | -4.8 Million | -1.64 Million | 253 Thousand |
| Other non-cash items | 3.05 Million | 13.01 Million | 4.32 Million | 6.57 Million | 5.31 Million | 6.3 Million |
| Investing Cash Flow | -23.06 Million | -3.53 Million | -2.54 Million | -2.92 Million | -1.87 Million | -617 Thousand |
| Investments in PPE | -23.06 Million | -3.53 Million | -2.54 Million | -2.17 Million | -1.41 Million | -617 Thousand |
| Acquisitions | - | - | - | -750 Thousand | -456 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -143 Thousand | -236 Thousand | -306 Thousand | -232 Thousand | -106 Thousand | -119 Thousand |
| Financing Cash Flow | 29.12 Million | 58.88 Million | 1.26 Million | 81.13 Million | 22.97 Million | 19.03 Million |
| Debt repayment | -9.03 Million | -16.49 Million | -15.35 Million | -7.79 Million | -13.04 Million | -22.51 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 643 Thousand | 355 Thousand | 328 Thousand | - | - | - |
| Common Stock Issuance | 28.86 Million | 60.03 Million | 17.44 Million | 72 Million | 10.04 Million | 31.55 Million |
| Other Financing Activities | 9.3 Million | 42.38 Million | 16.61 Million | 16.92 Million | 25.96 Million | 41.55 Million |
| Accounts receivables | -4.71 Million | -1.5 Million | 11.45 Million | -10.3 Million | -3.64 Million | -146 Thousand |
| Accounts payables | 513 Thousand | -773 Thousand | -7.42 Million | 11.65 Million | 1.19 Million | 342 Thousand |
| Inventory | 166 Thousand | 906 Thousand | 7.42 Million | -11.65 Million | 17 Thousand | -389 Thousand |
| Other working capital | 15.34 Million | -2.97 Million | -6.86 Million | 5.5 Million | 791 Thousand | 446 Thousand |
| Cash at beginning of period | 43.18 Million | 32.79 Million | 62.3 Million | 5.46 Million | 6.09 Million | 5.35 Million |
| Cash at end of period | 26.38 Million | 43.17 Million | 32.79 Million | 62.3 Million | 5.46 Million | 6.09 Million |
| Capital Expenditure | -23.06 Million | -3.53 Million | -2.54 Million | -2.17 Million | -1.41 Million | -617 Thousand |
| Effect of forex changes on cash | -1000.00 | - | - | - | - | - |
| Net cash flow / Change in cash | -16.8 Million | 10.37 Million | -29.5 Million | 56.83 Million | -626 Thousand | 738 Thousand |
| Free Cash Flow | -45.93 Million | -48.5 Million | -30.77 Million | -23.54 Million | -23.14 Million | -18.29 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.25 Million | -10.8 Million | -13.61 Million | -52.14 Million | -9.13 Million | -10.94 Million |
| Depreciation & Amortization | 1.41 Million | 1.31 Million | 1.32 Million | 5.5 Million | 1.3 Million | 1.23 Million |
| Deferred income taxes | - | - | - | 4.03 Million | -6.47 Million | 1.6 Million |
| Stock-based compensation | 1.51 Million | 1.21 Million | 2.64 Million | 5.37 Million | 1.08 Million | 954 Thousand |
| Change in working capital | 18.65 Million | -11.73 Million | -6.92 Million | 11.3 Million | -6.73 Million | -3.17 Million |
| Other non-cash items | -21.96 Million | 5.03 Million | 10.11 Million | 3.05 Million | 8.5 Million | 6.48 Million |
| Investing Cash Flow | -286 Thousand | -1.99 Million | -273 Thousand | -23.06 Million | -3 Million | -5.88 Million |
| Investments in PPE | -121 Thousand | -1.99 Million | -273 Thousand | -23.06 Million | -3 Million | -5.88 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -165 Thousand | -71 Thousand | -39 Thousand | -143 Thousand | -17 Thousand | -41 Thousand |
| Financing Cash Flow | 107 Thousand | 51.31 Million | 809 Thousand | 29.12 Million | 20.89 Million | 12.15 Million |
| Debt repayment | -13 Thousand | -12 Thousand | -13 Thousand | -9.03 Million | -9.07 Million | -12 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -5.05 Million | 5.39 Million | 282 Thousand | 643 Thousand | -3.03 Million | 3.26 Million |
| Common Stock Issuance | 3.32 Million | 51.4 Million | 892 Thousand | 28.86 Million | 12.87 Million | 14.89 Million |
| Other Financing Activities | 1.84 Million | -80 Thousand | -70 Thousand | 9.3 Million | 17.09 Million | -3.37 Million |
| Accounts receivables | 1.85 Million | -325 Thousand | -2.34 Million | -4.71 Million | -3.54 Million | -1.75 Million |
| Accounts payables | 622 Thousand | 555 Thousand | -1.23 Million | 513 Thousand | 760 Thousand | -1.48 Million |
| Inventory | 12 Thousand | - | 8000.00 | 166 Thousand | 1.92 Million | 1.48 Million |
| Other working capital | 15.31 Million | -11.96 Million | -3.35 Million | 15.34 Million | -3.95 Million | -1.42 Million |
| Cash at beginning of period | 42.31 Million | 11.59 Million | 26.38 Million | 43.18 Million | 19.94 Million | 17.49 Million |
| Cash at end of period | 31.49 Million | 42.31 Million | 11.59 Million | 26.38 Million | 26.38 Million | 19.92 Million |
| Capital Expenditure | -121 Thousand | -1.99 Million | -273 Thousand | -23.06 Million | -3 Million | -5.88 Million |
| Effect of forex changes on cash | - | - | - | -1000.00 | -1000.00 | 831 Thousand |
| Net cash flow / Change in cash | -10.82 Million | 30.72 Million | -14.79 Million | -16.8 Million | 6.44 Million | 2.43 Million |
| Free Cash Flow | -10.75 Million | -20.58 Million | -15.6 Million | -45.93 Million | -14.45 Million | -9.72 Million |
CNLHP
6066
RFHRF
NOW
VCSA
ALTME